Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
2,243,445
-
Shares change
-
-59,670
-
Total reported value, excl. options
-
$348,068,556
-
Value change
-
-$8,951,364
-
Number of buys
-
29
-
Number of sells
-
-46
-
Price
-
$155.13
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2017
102 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q2 2017.
ISHARES TR - U.S. PHARMA ETF (IHE) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,243,445 shares
.
Largest 10 shareholders include Clal Insurance Enterprises Holdings Ltd (892,282 shares), MORGAN STANLEY (223,247 shares), BANK OF AMERICA CORP /DE/ (172,134 shares), Pinnacle Advisory Group, Inc. (137,892 shares), ARS Wealth Advisors, LLC (80,541 shares), BROWN ADVISORY INC (63,663 shares), SPINNAKER TRUST (59,725 shares), GOLDMAN SACHS GROUP INC (55,626 shares), Round Table Services, LLC (44,719 shares), and CREDIT SUISSE AG/ (38,844 shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.